Today, a new and thorough review of the health impacts of glyphosate use is available to regulatory officials who are reviewing its re-approval as the world’s most widely used herbicide. 

The paper is titled Glyphosate, pathways to modern diseases IV: cancer and related pathologies. It’s published in the Journal of Biological Physics and Chemistry which is now being mailed to subscribers.

It’s a detailed analysis of scientific studies, including many of Monsanto’s own research originally presented to the U.S. government to gain regulatory approval. 

Authors are Anthony Samsel, research scientist at Deerfield, NH and Stephanie Seneff, researcher at the computer science and artificial intelligence laboratory, Massachusetts Institute of Technology, Cambridge, MA. These researchers have worked as a team on several previous studies. For this report, they also obtained via the Freedom of Information Act, an extensive body of lab studies submitted to EPA by Monsanto from the 1970s through the 1980s. 

The paper’s introduction includes this quote:

“Epidemiological evidence supports strong temporal correlations between glyphosate usage on crops and a multitude of cancers that are reaching epidemic proportions, including breast cancer, pancreatic cancer, kidney cancer, thyroid cancer, liver cancer, bladder cancer and myeloid leukaemia. Here, we support these correlations through an examination of Monsanto’s early studies on glyphosate, and explain how the biological effects of glyphosate could induce each of these cancers. We believe that the available evidence warrants a reconsideration of the risk/benefit trade-off with respect to glyphosate usage to control weeds, and we advocate much stricter regulation of glyphosate.”

We encourage you to download the 39-page paper as a PDF at this link, print it on your office printer and take a few days to read it, a section at a time. The information is very scientific and detailed, but also well-written and easily understood.